More pharma companies added in US price-fixing probe

More pharma companies added in US price-fixing probeProsecutors announced Tuesday they added 12 more companies and two executives as targets in a wide-ranging antitrust investigation that charges generic drug manufacturers fixed drug prices. The suit, which was filed in December and is now supported by prosecutors from 45 US states, alleges a broad conspiracy by Mylan Pharmaceuticals, Teva Pharmaceuticals and others to divvy up markets and set prices to boost profits at consumer’s expense. On Tuesday, attorneys general from the 45 states asked a federal court to allow them to increase the number of generic drug manufacturer defendants from six to 18, increase the number of drugs at issue in the litigation and name two executives as defendants.

Yahoo News – Latest News & Headlines